Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Lacticaseibacillus rhamnosus Probiotics Improve Fasting Blood Glucose, HOMA-IR, and Reduce Body Weight in Diabetic Rat Model

The Indonesian Biomedical Journal · Vol. 17 No. 1 (2025) · hlm. 90–98

DOI
10.18585/inabj.v17i1.3525
ISSN
2085-3297, 2355-9179
Terbit
2025-02-17
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Indonesian indigenous probiotics have been found to improve disruptions of tight junctions in the intestinal epithelium and reduce total cholesterol levels. Improvement in the tight junction could decrease the LPS level and further reduce the blood glucose and insulin resistance. The effects of indigenous Indonesian Lacticaseibacillus rhamnosus (Lr) probiotics on glucose metabolism and inflammatory marker levels in diabetic rats was studied to find if these probiotics are suitable as potential supplementation treatment in diabetes.METHODS: Sixteen female Wistar rats were induced with diabetes using streptozotocin and fed a high-fat, high-sucrose diet. The rats were separated into four groups: LrFBB81, LrFSMM22, LrSKG34, and a control group. Each intervention group got daily dosages of 1 mL probiotic suspensions containing 109 CFU/mL cells given orally for 14 days, whereas the control group received saline. Fasting blood glucose (FBG), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), lipopolysaccharide (LPS), and body weight were evaluated.RESULTS: FBG was significantly reduced in LrFSMM22 group (Δ=120.75 mg/dL, p=0.035), while significant reduction was not observed from LrFBB81, LrSKG34, and control groups. No statistically significant differences were found in HOMA-IR before and after intervention in all groups, but Δ HOMA-IR from LrFSMM22 group was reduced more than the control group (-3.90 vs. 2.02, p=0.028). All groups showed no significant differences in LPS level, meanwhile statistically significant reduction in body weight was observed in all probiotic groups, LrFBB81 (Δ=-15.7 gram, p=0.040), LrSKG34 (Δ= -20.43 gram, p=0.006), and LrFSMM22 groups (Δ=-18.33 gram, p=0.037).CONCLUSION: The administration of L. rhamnosus could improve FBG, HOMA-IR, and reduce body weight without suppressing the LPS.KEYWORDS: diabetes, probiotic, Lacticaseibacillus rhamnosus, fasting blood glucose, HOMA-IR, lipopolysaccharide, insulin resistance

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 146 tautan kepenulisan bersama · 37 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Udayana University
  • Universitas Airlangga
  • National Cheng Kung University
  • Eijkman Institute for Molecular Biology
  • Universitas Pendidikan Ganesha
  • Rumah Sakit Umum Pusat Sanglah Denpasar
  • State University of Semarang
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Anom SuardikaUdayana University2
Yenny KandariniUdayana University2
Ketut SuegaUdayana University2
I Made DarmayasaAfiliasi tidak diketahui2
I Made BaktaUdayana University1
Dyah Paramita DuarsaAfiliasi tidak diketahui1
Luh Seri AniUdayana University1
Luh MertasariUniversitas Pendidikan Ganesha1
Ni Made MertaniasihUniversitas Airlangga1
I Wayan Agus Gede Manik SaputraUniversitas Airlangga1
I Made JawiUdayana University1
Ni Nyoman Ayu DewiUdayana University1
Ni Gusti Ayu Manik ErmayantiUdayana University1
Endang Sri WidiyantiUdayana University1
I Gusti Ngurah Agung Satria WibawaUdayana University1
Divika SilvanaUdayana University1
Anak Agung Gede Raka BudayasaAfiliasi tidak diketahui1
H. Sunny SunNational Cheng Kung University1
Yen‐An TangNational Cheng Kung University1
Gede Wira MahaditaUdayana University1
Anak Agung Wiradewi LestariUdayana University1
Sianny HerawatiRumah Sakit Umum Pusat Sanglah Denpasar1
Made Ratna SaraswatiUdayana University1
Anak Agung Gde BudhiartaUdayana University1
Suksma OktavianthiEijkman Institute for Molecular Biology1
Safarina G. MalikEijkman Institute for Molecular Biology1
William WilliamUdayana University1
I Gede Mega PutraAfiliasi tidak diketahui1
Evert Solomon PangkahilaAfiliasi tidak diketahui1
Vidya Saraswati Putri DuarsaUdayana University1
Bambang PurwantoState University of Semarang1
Ni Wayan WinartiUdayana University1
Prayuda PrayudaUdayana University1
Ni Kadek MulyantariUdayana University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Lacticaseibacillus rhamnosus Probiotics Improve Fasting Blood Glucose, HOMA-IR, and Reduce Body Weight in Diabetic Rat Model</dc:title><dc:creator>Arresta Vitasatria Suastika</dc:creator><dc:creator>I Gde Raka Widiana</dc:creator><dc:creator>Anak Agung Ngurah Jaya Kusuma</dc:creator><dc:creator>Ni Nengah Dwi Fatmawati</dc:creator><dc:creator>Ketut Suastika</dc:creator><dc:creator>I Nengah Sujaya</dc:creator><dc:subject>glucose</dc:subject><dc:subject>insulin resistance</dc:subject><dc:subject>HOMA-IR</dc:subject><dc:subject>weight loss</dc:subject><dc:subject>streptozotocin-induced diabetes</dc:subject><dc:subject>high-fat high-sugar diet</dc:subject><dc:subject>glucose metabolism</dc:subject><dc:subject>intestinal tight junctions</dc:subject><dc:subject>probiotic strain selection</dc:subject><dc:subject>diabetes treatment</dc:subject><dc:subject>inflammation</dc:subject><dc:subject>gut microbiota</dc:subject><dc:subject>obesity</dc:subject><dc:subject>dyslipidemia</dc:subject><dc:description xml:lang="en">BACKGROUND: Indonesian indigenous probiotics have been found to improve disruptions of tight junctions in the intestinal epithelium and reduce total cholesterol levels. Improvement in the tight junction could decrease the LPS level and further reduce the blood glucose and insulin resistance. The effects of indigenous Indonesian Lacticaseibacillus rhamnosus (Lr) probiotics on glucose metabolism and inflammatory marker levels in diabetic rats was studied to find if these probiotics are suitable as potential supplementation treatment in diabetes.METHODS: Sixteen female Wistar rats were induced with diabetes using streptozotocin and fed a high-fat, high-sucrose diet. The rats were separated into four groups: LrFBB81, LrFSMM22, LrSKG34, and a control group. Each intervention group got daily dosages of 1 mL probiotic suspensions containing 109 CFU/mL cells given orally for 14 days, whereas the control group received saline. Fasting blood glucose (FBG), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), lipopolysaccharide (LPS), and body weight were evaluated.RESULTS: FBG was significantly reduced in LrFSMM22 group (Δ=120.75 mg/dL, p=0.035), while significant reduction was not observed from LrFBB81, LrSKG34, and control groups. No statistically significant differences were found in HOMA-IR before and after intervention in all groups, but Δ HOMA-IR from LrFSMM22 group was reduced more than the control group (-3.90 vs. 2.02, p=0.028). All groups showed no significant differences in LPS level, meanwhile statistically significant reduction in body weight was observed in all probiotic groups, LrFBB81 (Δ=-15.7 gram, p=0.040), LrSKG34 (Δ= -20.43 gram, p=0.006), and LrFSMM22 groups (Δ=-18.33 gram, p=0.037).CONCLUSION: The administration of L. rhamnosus could improve FBG, HOMA-IR, and reduce body weight without suppressing the LPS.KEYWORDS: diabetes, probiotic, Lacticaseibacillus rhamnosus, fasting blood glucose, HOMA-IR, lipopolysaccharide, insulin resistance</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2025-02-17</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v17i1.3525</dc:identifier><dc:identifier>10.18585/inabj.v17i1.3525</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 17 No 1 (2025); 90-98</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/3525/762</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>